Page 4 - Gianfranco Nazzi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gianfranco nazzi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gianfranco Nazzi Today - Breaking & Trending Today

Almirall's roadmap to a more sustainable future

Almirall’s roadmap to a more sustainable future·         The biopharmaceutical company reviews its Sustainability plan for the period 2021-2023 with 15 initiatives that will contribute to the achievement of the United Nations Sustainable Develo. ....

Sant Andreu , Comunidad Autonoma De Cataluna , Schleswig Holstein , Gianfranco Nazzi , Sant Feliu , Sant Celoni , Products Manufacturing Division , United Nations Sustainable Development Goals , United Nations Sustainable Development Goals Sdgs , Inclusion Program , Sustainable Procurement Program , Spanish Stock Exchange , Health Safety , Management Board , Chief Executive , Pharmaceutical Products Manufacturing , Noble Purpose ,

Cotización Almirall | Almirall celebra en bolsa los resultados de su medicamento contra la dermatitis

Cotización Almirall | Almirall celebra en bolsa los resultados de su medicamento contra la dermatitis
lainformacion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lainformacion.com Daily Mail and Mail on Sunday newspapers.

United States , Gianfranco Nazzi , Exchange Almirall , Agency Of Food , ஒன்றுபட்டது மாநிலங்களில் ,

Almirall delivers robust H1 performance and increases full-year guidance

Share this article
Share this article
BARCELONA, Spain, July 26, 2021 /PRNewswire/ Almirall, S.A. (BME: ALM), the global biopharmaceutical company based in Barcelona, has announced its H1 2021 financial results.
Summary of results H1
Core EBITDA increased 40.4% year-on-year to €125.6 MM driven by positive contribution from Growth Drivers
Normalised net income €57.8 MM
Net Loss of €42.8 MM due to an impairment of c.€100 MM for the carrying value of the intangible asset for Seysara® (€69 MM), the US Legacy Portfolio (€22 MM), and the Bioniz option payment which was not exercised (€12 MM)
Operating Cash Flow reached €109.8 MM
Core Net Sales excludes AstraZeneca Deferred Income
Core EBITDA excludes AstraZeneca Deferred Income and Other Income ....

Comunidad Autonoma De Cataluna , Prnewswire Almirall , Gianfranco Nazzi , Eli Lilly , European Commission , Growth Drivers , Cash Flow , Core Net Sales , Astrazeneca Deferred , Astrazeneca Deferred Income , Drivers Performance , Net Sales , Kaken Pharmaceutical , Core Guidance , காமுனிடட தன்னாட்சி டி கடலுள் , எலி லில்லி , ஐரோப்பிய தரகு , வளர்ச்சி இயக்கிகள் , பணம் ஓட்டம் , நிகர விற்பனை , கோர் வழிகாட்டல் ,

Cotización Almirall | Almirall se desploma en el Ibex 35 tras anunciar pérdidas en el primer semestre

Cotización Almirall | Almirall se desploma en el Ibex 35 tras anunciar pérdidas en el primer semestre
lainformacion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lainformacion.com Daily Mail and Mail on Sunday newspapers.

Gianfranco Nazzi , Prices Almirall ,

Almirall receives European Commission approval of Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis

Almirall receives European Commission approval of Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Comunidad Autonoma De Cataluna , Susana Puig , Prnewswire Almirall , Gianfranco Nazzi , European Commission , Dermatology Service , Chief Executive , Chief Dermatology Service , Hospital Clinic , New England Journal , Complete Clearance , காமுனிடட தன்னாட்சி டி கடலுள் , ஐரோப்பிய தரகு , தோல் நோய் சேவை , தலைமை நிர்வாகி , மருத்துவமனை சிகிச்சையகம் , புதியது இங்கிலாந்து இதழ் , முழுமை அனுமதி ,